Literature DB >> 18319590

14-3-3 zeta and tau genes interactively decrease Alzheimer's disease risk.

Ignacio Mateo1, Pascual Sánchez-Juan, Eloy Rodríguez-Rodríguez, Jon Infante, Carlos Fernández-Viadero, Nicolás Peña, José Berciano, Onofre Combarros.   

Abstract

Abnormal tau hyperphosphorylation has been suggested as being one of the central events in the development of neurofibrillary tangles, which are one of the characteristic neuropathological lesions found in Alzheimer's disease (AD) brains. 14-3-3 zeta protein is associated with tau in brain and stimulates tau phosphorylation. In a case-control study in 293 AD patients and 396 healthy controls, we examined whether the combined gene effects between 14-3-3 zeta (intron 4, rs 983583) polymorphism and tau (intron 9, rs 2471738) polymorphism might be responsible for susceptibility to AD. Subjects carrying both the 14-3-3 zeta (intron 4, rs 983583) AA and the tau (intron 9, rs 2471738) CC genotypes had a two and a half times lower risk of developing AD than subjects without these risk genotypes (OR = 0.4, 95% CI = 0.2-0.8, p = 0.016). Considering synergistic effects between polymorphisms in tau phosphorylation related genes may help in determining the risk profile for AD. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18319590     DOI: 10.1159/000119123

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  9 in total

Review 1.  Actin dynamics and cofilin-actin rods in alzheimer disease.

Authors:  James R Bamburg; Barbara W Bernstein
Journal:  Cytoskeleton (Hoboken)       Date:  2016-03-01

2.  A polymorphism in the YWHAH gene encoding 14-3-3 eta that is not associated with sporadic Creutzfeldt-Jakob disease (CJD).

Authors:  Jisuk Yun; Byung-Hoon Jeong; Hae-Jung Kim; Young-Jae Park; Yun-Jung Lee; Eun-Kyoung Choi; Richard I Carp; Yong-Sun Kim
Journal:  Mol Biol Rep       Date:  2011-07-08       Impact factor: 2.316

3.  14-3-3θ Does Not Protect against Behavioral or Pathological Deficits in Alzheimer's Disease Mouse Models.

Authors:  Mary Gannon; Bing Wang; Sara Anne Stringfellow; Stephan Quintin; Itzel Mendoza; Thanushri Srikantha; A Claire Roberts; Takashi Saito; Takaomi C Saido; Erik D Roberson; Talene A Yacoubian
Journal:  eNeuro       Date:  2022-06-24

Review 4.  14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases.

Authors:  F Sanders Pair; Talene A Yacoubian
Journal:  Trends Pharmacol Sci       Date:  2021-01-28       Impact factor: 14.819

5.  Concerted perturbation observed in a hub network in Alzheimer's disease.

Authors:  Dapeng Liang; Guangchun Han; Xuemei Feng; Jiya Sun; Yong Duan; Hongxing Lei
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

6.  Proteome-wide characterization of signalling interactions in the hippocampal CA4/DG subfield of patients with Alzheimer's disease.

Authors:  Jae Ho Kim; Julien Franck; Taewook Kang; Helmut Heinsen; Rivka Ravid; Isidro Ferrer; Mi Hee Cheon; Joo-Yong Lee; Jong Shin Yoo; Harry W Steinbusch; Michel Salzet; Isabelle Fournier; Young Mok Park
Journal:  Sci Rep       Date:  2015-06-10       Impact factor: 4.379

Review 7.  Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.

Authors:  Cheng-Cheng Zhang; Jun-Xia Zhu; Yu Wan; Lin Tan; Hui-Fu Wang; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2017-07-04

Review 8.  The associations between the MAPT polymorphisms and Alzheimer's disease risk: a meta-analysis.

Authors:  Futao Zhou; Danli Wang
Journal:  Oncotarget       Date:  2017-06-27

9.  14-3-3ζ loss leads to neonatal lethality by microRNA-126 downregulation-mediated developmental defects in lung vasculature.

Authors:  Jun Yang; Sonali Joshi; Qingfei Wang; Ping Li; Hai Wang; Yan Xiong; Yi Xiao; Jinyang Wang; Jan Parker-Thornburg; Richard R Behringer; Dihua Yu
Journal:  Cell Biosci       Date:  2017-11-02       Impact factor: 7.133

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.